Literature DB >> 6859966

Uric acid effects on in vitro models of rheumatoid inflammatory and autoimmune processes.

R A Turner, E J Pisko, C A Agudelo, G B Counts, S L Foster, W J Treadway.   

Abstract

A neutrophil monolayer system was used to study the effects of uric acid on neutrophil-aggregate interactions important in rheumatoid inflammation. No effect on immunoglobulin G aggregate phagocytosis was seen, but hyperuricaemic levels of uric acid were associated with an enhancement of phagocytosis-induced release of the azurophilic granular enzyme beta-glucuronidase. A trinitrophenyl-coupled mononuclear leucocyte rheumatoid factor plaque-forming assay was utilised to study uric acid effects on polyclonal activation of immunocompetent cells. Low levels of uric acid enhanced and high levels suppressed this system. Hyperuricaemia may enhance some aspects of rheumatoid inflammation, while uric acid may modulate an important component of rheumatoid autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6859966      PMCID: PMC1001143          DOI: 10.1136/ard.42.3.338

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  16 in total

1.  The phlogistic potential of urate in solution: studies of the phagocytic process in human leukocytes.

Authors:  S E Malawista; G Van Blaricom; S B Cretella; M L Schwartz
Journal:  Arthritis Rheum       Date:  1979-07

2.  Cell-mediated cytotoxicity to trinitrophenyl-modified syngeneic lymphocytes.

Authors:  G M Shearer
Journal:  Eur J Immunol       Date:  1974-08       Impact factor: 5.532

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Use of chromium chloride as the coupling agent in a modified plaque assay. Cells producing anti-protein antibody.

Authors:  G H Sweet; F L Welborn
Journal:  J Immunol       Date:  1971-05       Impact factor: 5.422

5.  Urate deposition disease. How is it regulated and how can it be modified?

Authors:  J R Klinenberg; R Bluestone; L Schlosstein; J Waisman; M W Whitehouse
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

6.  Generation of human plaque-forming cells in culture: tissue distribution, antigenic and cellular requirements.

Authors:  E W Gelfand
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

7.  Drug and rheumatoid factor effects on the uptake of immunoglobulin G aggregates by neurtrophil monolayers.

Authors:  R Turner; G Counts; H Mashburn; W Treadway; L DeChatelet
Journal:  Inflammation       Date:  1980-03       Impact factor: 4.092

8.  In vitro induction and measurement of hemolytic plaque forming cells in man.

Authors:  H M Dosch; E W Gelfand
Journal:  J Immunol Methods       Date:  1976       Impact factor: 2.303

9.  Human immune responses to hapten-conjugated cells. I. Primary and secondary proliferative responses in vitro.

Authors:  M F Seldin; R R Rich
Journal:  J Exp Med       Date:  1978-06-01       Impact factor: 14.307

10.  Neutrophil enzyme activities in rheumatoid inflammation.

Authors:  R Turner; M Martin; J Schroff; W Treadway; L DeChatelet
Journal:  Inflammation       Date:  1979-07       Impact factor: 4.092

View more
  1 in total

1.  Studies on the interaction of rheumatoid factor with monosodium urate crystals and case report of coexistent tophaceous gout and rheumatoid arthritis.

Authors:  T P Gordon; M J Ahern; C Reid; P J Roberts-Thomson
Journal:  Ann Rheum Dis       Date:  1985-06       Impact factor: 19.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.